Chris Collins is President, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria. He leads the organization’s efforts to engage U.S. decisionmakers on the lifesaving work of the Global Fund to Fight AIDS, Tuberculosis and Malaria and the importance of expanding global investment to bring these epidemics to an end. In 2019 he played a central role in multi-stakeholder advocacy to achieve the first increase in U.S. support to the Global Fund in six years, the third largest increase in the history of U.S. support.
Previously, as Chief of the Community Mobilization Division at UNAIDS, Chris helped make the case for investment in civil society as an essential part of the AIDS response. As Vice President and Director of Public Policy at amfAR, Chris defended global AIDS research and program funding and worked to advance domestic HIV policy and global key populations programming.
Chris authored the monograph that inspired the effort to create the first comprehensive U.S. National HIV/AIDS Strategy, then coordinated the successful advocacy push to establish the Strategy. As appropriations staff to Rep. Nancy Pelosi (D-CA) in the late 1990s, Chris designed the first legislation to provide incentives for development and delivery of vaccines against HIV, tuberculosis and malaria, a bill that helped advance the global dialogue on tackling major infectious diseases. He holds a master’s degree in public policy from the Kennedy School of Government at Harvard University
Mothers, Children, and the Terrible Choice Between COVID-19 and Other Infections
Decisive action is required now to protect the most vulnerable from HIV, tuberculosis, and malaria during the pandemic
How to Tackle Global Problems in an Age of Populism
Appetites for investment do exist today to define achievable goals, apply effective tools, and solve global challenges